Impaired Renal Function Should Not Be a Barrier to Transplantation in Patients With Cystic Fibrosis.

[1]  B. Tanriover,et al.  Association of pretransplant kidney function with outcomes after lung transplantation , 2017, Clinical transplantation.

[2]  M. Peltz,et al.  Hospital length of stay after lung transplantation: Independent predictors and association with early and late survival. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  D. Morales,et al.  Changing demographics and outcomes of lung transplantation recipients with cystic fibrosis. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  M. Carby,et al.  Challenging immunosuppression treatment in lung transplant recipients with kidney failure. , 2016, Transplant Immunology.

[5]  V. Valero,et al.  A novel risk score that incorporates recipient and donor variables to predict 1-year mortality in the current era of lung transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Ashish S Shah,et al.  Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  Josef Stehlik,et al.  The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  K. Raza,et al.  Immunosuppression in lung transplantation. , 2014, Journal of Thoracic Disease.

[9]  M. Stafford-Smith,et al.  Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation. , 2014, The Annals of thoracic surgery.

[10]  A. Rule,et al.  Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients. , 2014, American Journal of Kidney Diseases.

[11]  M. Stafford-Smith,et al.  Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate. , 2014, The Journal of Heart and Lung Transplantation.

[12]  Charles M. Miller,et al.  An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. , 2010, American Society of Nephrology. Clinical Journal.

[13]  C. Magee,et al.  A CF patient with progressive proteinuric renal disease: a CF-specific nodular glomerulosclerosis? , 2010, NDT plus.

[14]  R. Yusen,et al.  Lung Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  J J Fung,et al.  Liver Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  C. Merlo,et al.  Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data. , 2009, Journal of the American College of Surgeons.

[17]  T. Nickolas,et al.  The modification of diet in renal disease (MDRD) and the prediction of kidney outcomes after lung transplantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  E. Trulock,et al.  The new lung allocation system and its impact on waitlist characteristics and post-transplant outcomes. , 2008, Seminars in Thoracic and Cardiovascular Surgery.

[19]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[20]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[21]  F L Grover,et al.  Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  S. Keshavjee,et al.  The effect of recipient's age on lung transplant outcome. , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  P. Nyckowski,et al.  Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. , 2003, Transplantation proceedings.

[24]  S. E. Stephens,et al.  Cystic fibrosis and renal disease. , 2002, Paediatric respiratory reviews.

[25]  F. Martinez,et al.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  J. Maurer Impact of U.S. Lung Allocation Score on Survival After Lung Transplantation , 2010 .

[27]  B. Miller Chronic kidney disease in solid-organ transplantation. , 2006, Advances in chronic kidney disease.

[28]  Keith McNeil,et al.  International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). , 1998, American journal of respiratory and critical care medicine.

[29]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.